Company Description
Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally.
It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.
The Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products.
The Montana/Renewables segment focuses on processing renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha.
It also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt.
The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands.
The company serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.
Country | United States |
Founded | 1916 |
IPO Date | Jan 26, 2006 |
Industry | Oil & Gas Exploration & Production |
Sector | Energy |
Employees | 1,580 |
CEO | Louis Borgmann |
Contact Details
Address: 1060 N Capitol Ave, Suite 6-401 Indianapolis, Indiana 46204-1044 United States | |
Phone | 317-328-5660 |
Website | calumet.com |
Stock Details
Ticker Symbol | CLMT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001340122 |
CUSIP Number | 131476103 |
ISIN Number | US1314761032 |
Employer ID | 35-1811116 |
SIC Code | 2911 |
Key Executives
Name | Position |
---|---|
Louis Todd Borgmann | President, Chief Executive Officer and Director of Calumet GP, LLC |
Vincent Donargo | Chief Accounting Officer and Principal Accounting Officer |
Gregory J. Morical | Senior Vice President, General Counsel and Secretary of Calumet GP, LLC |
Scott Obermeier | Executive Vice President of Specialties of Calumet GP, LLC |
David A. Lunin | Executive Vice President and Chief Financial Officer of Calumet GP, LLC |
John Kompa | Director of Investor Relations |
Chris Hodges | Alpha IR |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 1, 2024 | 15-12G | Securities registration termination |
Aug 1, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Aug 1, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Aug 1, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Aug 1, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Aug 1, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Jul 10, 2024 | 8-K | Current Report |
Jul 5, 2024 | 8-K | Current Report |
Jun 7, 2024 | DEFM14A | Filing |
May 10, 2024 | 10-Q | Quarterly Report |